Medium in Biological Technology
Navigation Links
Medium in Biological Technology
... announced the release of MesenCult®-ACF medium , the first defined, animal component-free (ACF) and serum-free medium for culturing human mesenchymal stem cells ... animal component-free (ACF) and serum-free medium for culturing human mesenchymal stem cells ....
... across the globe representing small, medium and large pharmaceutical companies and provides a ... (32%) and more than a third working in small to medium companies (36%). Another 10% of respondents work ... sciences industry, with large as well as small to medium sized companies participating," said Jim Nichols, ...
... AFRIN PureSea Nasal Rinse is available in three forms of delivery -- medium Stream, Gentle Mist, and Ultra-Gentle Mist -- and can be found at most drug stores, mass retailers, and grocery stores nationwide. Both the medium Stream and Gentle Mist are designed for use in adults and children ages 2 ...
... ), the most popular scientific website in China. Both of these media outlets are affiliated with Science Times, which is the official medium of Chinese Academy of Sciences (CAS). About Elsevier Elsevier is a world-leading publisher of scientific, technical and medical ...
... Neuromics, Inc. of Edina, MN, giving Neuromics the right to non-exclusively market and sell the ArunA hN2(TM) Human Neural Cells and Neural Culture medium to support applications in neurological research. (Logo: http://www.newscom.com/cgi-bin/prnh/20080819/CLTU003LOGO ) ArunA has an ...
... culture analysis and for molecular diagnostic assays, as well as producing innovations, like the patented Flocked Swabs, Universal Transport medium and ESwab. The company manufactures a comprehensive line of laboratory consumables comprising of inoculation loops, needles, spreaders and transfer ...
... from compliance errors that can lead to adverse regulatory action by the FDA. Throughout the product lifecycle, better use of resources by small and medium sized firms and wise allocation of funding can lead to more success with the FDA review process. In 2008 GZP dramatically increased the number of ...
... The Netherlands. They successfully achieved 8 grams per liter for an IgG expressed by PER.C6(R) cells using chemically defined cell culture medium in a SUB (single-use bioreactor). This result confirms a reliable, versatile and commercially feasible production platform to manufacture large ...
Inno-Tech Show 2008 will be held in Seoul
... -- The largest event for small and medium business in Korea -- 500 small and medium business in sectors such as biotechnology, ... Inno-Tech 2008 will be sponsored by the Small and medium Business Administration and organized by the ...... across the globe representing small, medium and large pharmaceutical companies and provides a ... (32%) and more than a third working in small to medium companies (36%). Another 10% of respondents work ... sciences industry, with large as well as small to medium sized companies participating," said Jim Nichols, ...
iCardiac Selected for Multiple Cardiac Safety Studies
... and automated QT analysis, announced that it has been chosen by a medium sized pharmaceutical company for cardiac safety evaluation comprising ... a decade in cardiac clinical trials conducted for and by leading large and medium sized pharmaceutical, biotechnology, and medical device companies. For ...... AFRIN PureSea Nasal Rinse is available in three forms of delivery -- medium Stream, Gentle Mist, and Ultra-Gentle Mist -- and can be found at most drug stores, mass retailers, and grocery stores nationwide. Both the medium Stream and Gentle Mist are designed for use in adults and children ages 2 ...
iCardiac Expands Sales and Marketing Team
... drugs in development. iCardiac's COMPAS technology has been used for over a decade in cardiac clinical trials conducted for and by leading large and medium sized pharmaceutical, biotechnology, and medical device companies. For more information, visit: www.icardiac.com . # # # Read the full story ...iCardiac Processes Volume of Data Equivalent to One Thousand Traditional Thorough QT Studies
... drugs in development. iCardiac's COMPAS technology has been used for over a decade in cardiac clinical trials conducted for and by leading large and medium sized pharmaceutical, biotechnology, and medical device companies. For more information, visit: www.icardiac.com . ### Read the full story at ...Breaking barriers with nanoscale lasers
... 1,500 nanometers, so a 750-nanometer laser was thought to be the smallest a laser could be made for optical communications. In an optically denser medium such as a semiconductor, this limit is reduced by a factor of the index of refraction (expressed mathematically as ~3.0) of a semiconductor in this ...Time Clocks Technology Catches Up With Crooks
... work station you hang out with your mate upstairs in R&D. What's to stop that from happening? David Azzopardi: "Whichever recognition medium is used (fingerprint, proximity tag or pin code), access control employee time clocks mean the door only opens for you if you're authorised, or they ...Study on keeping nuclear bombs from US ports shows misplaced fear over cargo scanning cost
... number of containers virtually all those originating outside the U.S. would receive a rapid screening via low-cost, drive-through radiation and medium energy x-ray radiographic portals as they enter an international port. Containers that fail will not be placed in stacks for outbound containers, but ...iCardiac Selected by Top 10 Pharmaceutical Company
... drugs in development. iCardiac's COMPAS technology has been used for over a decade in cardiac clinical trials conducted for and by leading large and medium sized pharmaceutical, biotechnology, and medical device companies. For more information, visit: www.icardiac.com . ### Read the full story at ...UCF team's advanced nerve cell system could help cure diabetic neuropathy, related diseases
... for growing various nervous system cells in serum-free media, including motoneurons, so they decided to attempt myelination using the growth medium they have spent years tweaking. Hickman hypothesizes that while serum contains components that promote cell growth it may also contain some that ...Government Mandates Create Guaranteed Market for Bio-Fuel, Says Frost & Sullivan
... especially for Malaysia and Singapore, that are focusing on export markets such as the European Union are expected to remain strong in the short and medium terms. "The substantial increase in bio-diesel production capacity in the region is a clear sign of the industry going beyond its niche status ...GeneThera Extends its Reach Overseas
... the Ministry for International Commerce, ICE, Filas S.p.A. and the Zangani Investor Community. During the two-day event big pharma, small and medium size enterprises, research and university centers presented their products, research projects and technologies. The Conference foreign delegation ...A billion-year ultra-dense memory chip
... Berkeley National Laboratory (Berkeley Lab) and the University of California (UC) Berkeley have smashed this tradition with a new memory storage medium that can pack thousands of times more data into one square inch of space than conventional chips and retain this data for more than a billion years! ...... ), the most popular scientific website in China. Both of these media outlets are affiliated with Science Times, which is the official medium of Chinese Academy of Sciences (CAS). About Elsevier Elsevier is a world-leading publisher of scientific, technical and medical ...
Recombinant C-Reactive Protein
... Inflammation is also believed to play a role in the initiation and progression of cardiovascular disease. r-hCRP is produced into culture medium by DNA recombinant procedure in E. Coli as secretory protein. By expressing kil gene, the outer membrane of E. Coli becomes permeable, allowing ...Avoiding False Positives Key Priority in Cardiac Safety Studies
... drugs in development. iCardiac's COMPAS technology has been used for over a decade in cardiac clinical trials conducted for and by leading large and medium sized pharmaceutical, biotechnology, and medical device companies. For more information, visit: www.icardiac.com . ### Read the full story at ...University of Maryland Announces Finalists for $75K Business Plan Competition
... message requests for information received from customers. As the first fully automated national provider of mobile marketing solutions for small and medium sized businesses, Inari will provide its clients with a simple, affordable solution to supplement their current advertising campaigns. ...iCardiac Applies Advanced Cardiac Safety Biomarkers in Clinical Study for Top Pharmaceutical Company
... drugs in development. iCardiac's COMPAS technology has been used for over a decade in cardiac clinical trials conducted for and by leading large and medium sized pharmaceutical, biotechnology, and medical device companies. For more information, visit: www.icardiac.com . ### Read the full story at ...... Neuromics, Inc. of Edina, MN, giving Neuromics the right to non-exclusively market and sell the ArunA hN2(TM) Human Neural Cells and Neural Culture medium to support applications in neurological research. (Logo: http://www.newscom.com/cgi-bin/prnh/20080819/CLTU003LOGO ) ArunA has an ...
iCardiac Reports Significant Revenue Growth and Profitability
... drugs in development. iCardiac's COMPAS technology has been used for over a decade in cardiac clinical trials conducted for and by leading large and medium sized pharmaceutical, biotechnology, and medical device companies. For more information, visit: www.icardiac.com . ### Read the full story at ...... culture analysis and for molecular diagnostic assays, as well as producing innovations, like the patented Flocked Swabs, Universal Transport medium and ESwab. The company manufactures a comprehensive line of laboratory consumables comprising of inoculation loops, needles, spreaders and transfer ...
Heinlein Trust and SpaceX Announce Competition to Promote Research Innovation in Zero Gravity
... space transportation, ultimately by a factor of ten. With the Falcon 1 and Falcon 9 vehicles, SpaceX offers highly reliable/cost-efficient light, medium and heavy lift capabilities for spacecraft insertion into any orbital altitude and inclination. In addition, the Dragon spacecraft provides Earth to ...DAZ Systems, Inc. Showcases Oracle Business Accelerator for Agile Product Lifecycle Management
... and Siebel. With a rich understanding of Oracle technology, DAZ has delivered over 280 mission critical Oracle based solutions to Fortune 1000 and medium sized enterprises. In addition, DAZ has adopted the Oracle Accelerate solution and is certified with the Oracle Business Accelerators. DAZ Systems is ...Seasonal Influenza Activity Increasing Across Europe - H3N2 Dominant Strain
... activity is increasing rapidly across Europe. The first countries to report high intensity of influenza activity were Portugal and Ireland. To date, medium or high intensity activity has been reported in nineteen countries.(1) Of 2488 viruses which have been typed and sub-typed in Europe so far this ...Sigma-Aldrich Acquires Seppro(R) Depletion Technology From GenWay Biotech
... the most complete human depletion system available, removing 14 of the most abundant proteins from human serum or plasma, as well as other high and medium abundant proteins. Additional products are available for the depletion of mouse and rat samples, as well as the industry's only depletion system for ...Technique for Creating Authentic Rat Embryonic Stem Cells Published in Cell
... terms of its agreement with Edinburgh University , SCS has global exclusive rights to commercialise pluripotent rat stem cells, the specific culture medium used to generate and grow the cells, and rats derived therefrom. Dr Alastair Riddell, Chief Executive Officer of Stem Cell Sciences, ...New one-of-a-kind technology will fly on 2 NASA missions
... data and imagery to be used in agriculture, education, business, science, and government. The Landsat Program provides repetitive acquisition of medium resolution near-infrared and visible data of the Earth's surface on a global basis. The MMS will have four spacecraft acting in concert to ...New one-of-a-kind technology will fly on two NASA missions
... data and imagery to be used in agriculture, education, business, science, and government. The Landsat Program provides repetitive acquisition of medium resolution near-infrared and visible data of the Earth's surface on a global basis. The MMS will have four spacecraft acting in concert to ...DAZ Systems, Inc. Thrives in the Clean Energy Industry
... and Siebel. With a rich understanding of Oracle technology, DAZ has delivered over 180 mission critical Oracle based solutions to Fortune 1000 and medium sized enterprises. In addition, DAZ has adopted the Oracle Accelerate solution and is certified on OBA for the Consumer Products industry. For ...Duska Therapeutics Provides Program Update and Reports Third Quarter 2008 Financial Results
... next year. -- Acquisition of exclusive worldwide rights for ATPotent, a novel adenosine 5'-triphosphate (ATP)-based sperm-processing medium designed to enhance sperm motility and reduce the failure rates of in vitro fertilization (IVF) and intrauterine insemination (IUI) ...Surface plasmon resonances of metal nanoparticles in array can have narrower spectral widths
... of sharp plasmon resonance peaks. "The narrow peaks occur when the product of the nanoparticle spacing and the refractive index of the surrounding medium approximately matches the plasmon resonance wavelength of a single nanoparticle," explained Crozier. Over the past several years, Crozier and his ...... from compliance errors that can lead to adverse regulatory action by the FDA. Throughout the product lifecycle, better use of resources by small and medium sized firms and wise allocation of funding can lead to more success with the FDA review process. In 2008 GZP dramatically increased the number of ...
... The Netherlands. They successfully achieved 8 grams per liter for an IgG expressed by PER.C6(R) cells using chemically defined cell culture medium in a SUB (single-use bioreactor). This result confirms a reliable, versatile and commercially feasible production platform to manufacture large ...
As personalized, genomic medicine takes off, four developing countries show the way for others
... and health ministries); legislators considering research funding; leaders of research institutions; individual scientists; investors and small and medium private sector enterprises in both industrialized and developing countries, and international organizations interested in the use of science and ...KGI Offers Mammalian Cell Culture Program for Biotech Industry Professionals
... held in the Amgen Bioprocessing Center at KGI. The lectures will cover a broad range of issues, from cell line engineering and design of culture medium to control of cell metabolism and operation of high density fed-batch cultures in large-scale bioreactors. In keeping with KGI's hands-on learning ...CBDM.T, The Market and Business Intelligence Company Reviews The Biomanufacturing Market
... companies with significant manufacturing capacity such as Amgen or Genentech, access to biomanufacturing capacity is less critical than for small and medium size companies which rely on CMOs to reduce the financial risk" comments Philippe Tramoy, managing partner. Key players: Amgen, Wyeth, GSK, ...Professor-turned-producer learns the movie biz
... vehicle to propagate this important scientific and educational message, it was imperative that the team not allow the core properties of the medium immersive, engaging entertainment to take a back seat. "After watching the movie, parents, children, and teachers all rave about the storyline, ...Essilor's First-Half 2008 Results
... variable-tint lenses as well as the Crizal Avance(TM) anti-reflective lenses with Scotchgard(TM) Protector. - A sharp increase in sales of medium and high-index lenses, especially in 1.6 high-index material. Revenue by region EUR millions First-half First-half % change % ...Other ContentspituitarypituitarypituitarypituitarypituitarypituitarypituitaryplacentaplacentaplacentaplacentamammalsmammalsmammalsmammalsmammalsmammalsplacentalplacentalplacentalplacentalplacentalplaqueplaqueplaqueplaqueplaqueplaqueplaqueplaqueplastidOther TagsTARCTARCablablablablablablabl
(Date:11/25/2009)...University assistant professors recently received ... to continue research beneficial to understanding ..., Christopher Blackwood, assistant professor in ... grants to support two separate research projects....Decomposer Communities and Functions from the Leaf...
(Date:11/24/2009)...f years it has been prescribed by traditional heal...adaches and stomach pain to fever and flu. , Now ...rsity have been able to scientifically prove the p...rwise known as Brazilian mint. , Testing this anc...researcher Graciela Rocha was able to show that wh...
(Date:11/24/2009)...is opening new doors to understanding how sounds a... of a marine mammal or if they hear it at all. ,...anners that NASA uses to detect flaws in the space...wing scientists to peek inside the giant head of a...ensional replicas of a whale,s hearing anatomy usi...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2Got a pain? -- Have a cup of Brazilian mint 2Rocket science leads to new whale discovery 2Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 50697 1Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 50697 2Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 50697 3Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 50697 4Dr Julian Whitaker Featured on Searchjointpain com 50694 1Dr Julian Whitaker Featured on Searchjointpain com 50694 2ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB 402 4677 1ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB 402 4677 2ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB 402 4677 3ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB 402 4677 4ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB 402 4677 5(Date:11/28/2009)...nsider change after 30-minute psychosocial interve...HealthDay News) -- A program that gets persistent ...ir dangerous behavior may lead to significant and ... The new study included 184 men and women with two...ere randomly assigned to one of two interventions....
(Date:11/27/2009)...Replikins Ltd. today issued its latest biochemical...s that the lethality of the virus has dropped from...rent outbreak in the spring of 2009 to resting non...H1N1 infectivity count, however, remains increased...er 27, 2009 -- Biotech firm Replikins Ltd., which ...
(Date:11/27/2009)... 27 Shamir Optical Indus...provider of innovative products and technology to ...ts board of directors had declared a dividend dist...(approximately NIS 37.62 million based on the Nove... approximately US$ 0.609 (approximately NIS 2.3 ba...
(Date:11/27/2009)...™ announced today that Spectrum Health (Gran...erprise orthopedic templating solution and its Tra... (PRWEB) November 27, 2009 -- Voyant Heal...and Rapids, Michigan) has licensed its TraumaCad E...raumaCad Extend workflow solution, to allow its or...
(Date:11/26/2009)... The diabetes population in the Uni...rs and annual medical spending on the disease is p... today, according to a study published in the Dece...ging Diabetes ® Program (NCDP), a program of ...from the University of Chicago. ,, According to...
Breaking Medicine News(10 mins):Health News:Drunk Drivers May Respond to Brief Motivational Interview 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4[1] Drunk Drivers May Respond to Brief Motivational Interview[0] Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased[0] Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend[0] Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend[1] Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows
SpUlp2SchizosaccharomycesaminoterminalSTX18PhosphohydrolaseCLBPhosphoserineProlineTARCablBcrThioredoxinsRANKLisoleucine
Other Tagsecosystem 2declared 2declared 3declared 4declared 5declared 6declared 7declared 8declared 9declared 10suspects 2suspects 3equal 2equal 3services 2services 3services 4services 5
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |